BioGeneration Ventures invests in early to growth-stage European life sciences companies, focusing on innovative healthcare, biotech, and medtech startups primarily in the Netherlands and Germany. Their thesis centers on translating scientific breakthroughs into impactful commercial therapies and technologies.